Masaki Shiota

110PUBLICATIONS
122CO-AUTHORS
Predictive and prognostic markersMedical genetics (excl. cancer genetics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Navigation and position fixing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (110)

|Sep 16, 2026
Survival benchmarking of talazoparib plus enzalutamide in homologous recombination repair-deficient metastatic castration-resistant prostate cancer: a reconstructed individual patient data analysis.

|Sep 14, 2026
The Complementary Roles of the Prostate Health Index and Multiparametric Magnetic Resonance Imaging in Optimizing the Detection of Clinically Significant Prostate Cancer in Patients With Prostate-Specific Antigen Levels Below 10 Ng/mL.

|Sep 14, 2026
Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real-World Data From Japan.

|Jul 13, 2026
Proteomic Analysis Reveals AMPKα-Mediated Antiandrogen Resistance via Ferroptosis Suppression in Prostate Cancer.

|Jun 26, 2026
Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401.

|Jun 09, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study.

Pageof 19

Frequent Collaborators

12 joint publications

Leandro Blas

10 joint publications

Masatoshi Eto

7 joint publications

Akira Yokomizo

7 joint publications

Hiroaki Matsumoto